Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck CancerChang Xu, Eduardo Méndez, Olga Nikolova et al.|Clinical Cancer Research|2018Cited by 25
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAILRussell Moser, Christopher J. Kemp, James Annis et al.|Cancer Research|2022Cited by 11
Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinomaRussell Moser, Christopher J. Kemp, Kay E. Gurley et al.|Oncogene|2022Cited by 7
Supplementary Figure from Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAILRussell Moser, Christopher J. Kemp, J. Annis et al.|Unknown|2023Cited by 0
Supplementary Data from Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAILRussell Moser, Christopher J. Kemp, J. Annis et al.|Unknown|2023Cited by 0